ZMUni Compliance Centre

China's cosmetic electronic label (e-label) pilot program continues to expand at the provincial level, with both Shanghai and Zhejiang officially releasing their first batches of pilot companies.   On January 23, 2026, the Shanghai Municipal Medical Products Administration (Shanghai MPA) announced the first batch of 40 pilot companies for the city's cosmetic e-label program. Shanghai Guiyan Technology Co., Ltd., a wholly owned subsidiary of ZMUni Compliance Centre, was selected as a pilot participant, recognizing its compliance expertise and digital service capabilities.   Shortly thereafter, on January 30, 2026, the Zhejiang Provincial Medical Products Administration released its first batch of cosmetic

As global regulatory frameworks for cosmetics and food continue to evolve, companies are facing increasingly detailed requirements around ingredient safety, scientific assessment, and market access. Keeping pace with these changes has become an essential part of everyday regulatory and compliance work.   Throughout 2025, ZMUni Compliance Centre has closely tracked regulatory developments across China and major international markets, while continuing to support clients through practical compliance consulting and project-based regulatory services. Alongside this work, we have also continued to share regulatory updates and practical insights through our website, industry events, and professional communication channels.   Based on this ongoing monitoring and

From January 16 to 23, 2026, 3 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA).     The technical requirements for the 3 NCIs mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.   Marubi's Fifth NCI Notification Gynura divaricata (L.) DC., a member of the Gynura genus in the Asteraceae family, is recognized in China as a medicinal and edible plant. It contains a range of bioactive constituents, including polysaccharides, flavonoids, alkaloids, and anthraquinones, and is associated with anti-inflammatory, hepatoprotective, and lipid-lowering activities.   In 2010, China's former Ministry of Health (now the National Health

    On January 15, 2026, China's State Administration for Market Regulation (SAMR) officially added a new health function to the Health Function Catalogue Allowed for Health Food Claims - Helps Maintain Bone and Joint Health (Alleviates Pain or Stiffness/Alleviates Cartilage Damage).   This marks the first new function included in the catalogue following the release of the Administrative Measures on Directory of Health Food Raw Materials and Directory of Health Functions and the Detailed Rules on Implementation for Technical Evaluation of New Functions and Health Food with New Functions (Trial). The move represents a significant step in expanding health claims

From January 1 to 15, 2026, 11 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA).   The technical requirements for the 11 NCIs mentioned above have not been disclosed, and they have not yet entered the safety monitoring period. Of these, seven are botanical extracts, while the others include peptides, fermented ingredients, and biosynthesized ingredients.   Ganoderma Leucocontextum Fruiting Body Extract Ganoderma leucocontextum, primarily found on the Qinghai–Tibet Plateau, was identified as a new Ganoderma species in 2015, named for its characteristic white flesh. Recent studies have advanced understanding of its chemical composition and pharmacological properties.   The Notifer is a wholly-owned subsidiary of

    On January 15, 2025, China's National Institute for Food and Drug Control(NIFDC) opened public consultation on three cosmetic standards, namely:   Determination of Trivalent Chromium and Hexavalent Chromium in Cosmetics Determination of 1-hydroxyethyl-4,5-diaminopyrazole sulfate and other 10 kinds of ingredients in cosmetics Determination of Ethyl Lauroyl Arginate HCl in Cosmetics   Stakeholders are invited to submit comments via the Cosmetic Standards Revision Management System (https://www.nifdc.org.cn/nifdc/bshff/hzhpbzh/hzhpbzhxt/index.html) by February 24, 2026.

  On January 12, 2026, China's National Medical Products Administration (NMPA) issued three announcements (No. 1, No. 5, and No. 6 of 2026), formally incorporating 27 new and updated testing standards, covering the addition and revision of testing methods for 177 cosmetic ingredients, into the Safety Technical Standards for Cosmetics (2015 edition).   The standards and methods covered by these announcements were previously released for public consultation between June and September 2025 and have now been formally adopted.   Details are outlined below:   Announcement No.1 of 2026 No. Standard/Method Type 1 Determination of Cannabidiol and Other 5 Kinds of

    On January 12, 2025, China's National Medical Products Administration (NMPA) issued a new supplementary testing method: BJH 202502 Determination of Sudan I (CI 12055) and Other 3 Kinds of Ingredients in Cosmetic.    This method specifies the determination of Sudan I (CI 12055), Sudan II (CI 12140), Sudan III (CI 26100), and Sudan IV (CI 26105) in cosmetic products. It is applicable to the quantitative determination of these dyes in liquid (aqueous and oil-based), cream/ointment, powder, solid, and wax-based cosmetic formulations.   The release follows the October 2025 Sudan red incident, when several skincare products from major brands tested positive for Sudan